Agile Therapeutics (AGRX) PT Lowered to $5 at RBC Capital
Tweet
Share
E-mailGet Alerts AGRX Hot Sheet
Price: $1.51 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
RBC Capital analyst Daniel Busb lowered the price target on Agile Therapeutics (NASDAQ: AGRX) to $5.00 (from $6.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Citi Upgrades a2 Milk Co (A2M:AU) (ACOPF) to Buy
- Citi Downgrades Northern Star Resources (NST:AU) (NESRF) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
